Evidence map›Paper›PMID 38257323›Full record

ReviewMolecules (Basel, Switzerland)2024

The Neurotherapeutic Arsenal in

Ahmad K Al-Khazaleh, Xian Zhou, Deep Jyoti Bhuyan, Gerald W Münch, Elaf Adel Al-Dalabeeh, Kayla Jaye, Dennis Chang

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
19.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. CNR1 and CNR2 Cannabinoid Receptor Mutations in Cancer Cells.Current issues in molecular biology · 2026
    Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Beyond Cannabidiol: The Contribution ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Ahmad K Al-KhazalehNICM Health Research Institute, Western Sydney University, Penrith, NSW 2751, Australia.ORCID 0000-0003-0635-0426
Xian ZhouNICM Health Research Institute, Western Sydney University, Penrith, NSW 2751, Australia.ORCID 0000-0001-8766-8158
Deep Jyoti BhuyanNICM Health Research Institute, Western Sydney University, Penrith, NSW 2751, Australia.ORCID 0000-0002-9736-0197
Gerald W MünchNICM Health Research Institute, Western Sydney University, Penrith, NSW 2751, Australia.
Elaf Adel Al-DalabeehDepartment of Biological Sciences, School of Science, University of Jordan, Amman 11942, Jordan.
Kayla JayeNICM Health Research Institute, Western Sydney University, Penrith, NSW 2751, Australia.ORCID 0000-0001-7809-3401
Dennis ChangNICM Health Research Institute, Western Sydney University, Penrith, NSW 2751, Australia.
Western Sydney University · AUUniversity of Jordan · JO

Funding

Western Sydney University N/A
6 · The paper itself

Abstract

Cannabis, renowned for its historical medicinal use, harbours various bioactive compounds-cannabinoids, terpenes, and flavonoids. While major cannabinoids like delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) have received extensive scrutiny for their pharmacological properties, emerging evidence underscores the collaborative interactions among these constituents, suggesting a collective therapeutic potential. This comprehensive review explores the intricate relationships and synergies between cannabinoids, terpenes, and flavonoids in cannabis. Cannabinoids, pivotal in cannabis's bioactivity, exhibit well-documented analgesic, anti-inflammatory, and neuroprotective effects. Terpenes, aromatic compounds imbuing distinct flavours, not only contribute to cannabis's sensory profile but also modulate cannabinoid effects through diverse molecular mechanisms. Flavonoids, another cannabis component, demonstrate anti-inflammatory, antioxidant, and neuroprotective properties, particularly relevant to neuroinflammation. The entourage hypothesis posits that combined cannabinoid, terpene, and flavonoid action yields synergistic or additive effects, surpassing individual compound efficacy. Recognizing the nuanced interactions is crucial for unravelling cannabis's complete therapeutic potential. Tailoring treatments based on the holistic composition of cannabis strains allows optimization of therapeutic outcomes while minimizing potential side effects. This review underscores the imperative to delve into the intricate roles of cannabinoids, terpenes, and flavonoids, offering promising prospects for innovative therapeutic interventions and advocating continued research to unlock cannabis's full therapeutic potential within the realm of natural plant-based medicine.

Indexed as

CannabidiolCannabisHallucinogensAnti-Inflammatory AgentsCannabinoid Receptor AgonistsFlavonoidsNeuroinflammatory DiseasesTerpenesAnti-Inflammatory AgentsCannabidiolCannabinoid Receptor AgonistsFlavonoidsHallucinogensTerpenescannabinoidsCannabis sativaentourage effectsflavonoidsneuroinflammatoryneuroprotective diseasesphytochemicalssynergistic effectsterpenes

Identifiers

PMID38257323
PMCPMC10821245
OpenAlexW4390879525

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.